Treatment outcome in infant acute lymphoblastic leukemia

被引：0

作者：

Ferster, A ^{[1
]}

Benoit, Y ^{[1
]}

Francotte, N ^{[1
]}

Dresse, MF ^{[1
]}

Uyttebroeck, A ^{[1
]}

Plouvier, E ^{[1
]}

Thyss, A ^{[1
]}

Lutz, P ^{[1
]}

Marguerite, G ^{[1
]}

Behar, C ^{[1
]}

Mazingue, F ^{[1
]}

Boutard, P ^{[1
]}

Millot, F ^{[1
]}

Rialland, X ^{[1
]}

Mechinaud, F ^{[1
]}

Norton, L ^{[1
]}

Robert, A ^{[1
]}

Otten, J ^{[1
]}

Vilmer, E ^{[1
]}

Philippe, N ^{[1
]}

Waterkeyn, C ^{[1
]}

Suciu, S ^{[1
]}

机构：

[1] Hop Univ Enfants Reine Fabiola, EORTC, Children Leukemia Cooperat Grp, Brussels, Belgium

来源：

BLOOD | 2000年 / 95卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2729 / 2730

页数：2

共 50 条

[1] Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia
Dördelmann, M
Reiter, A
Borkhardt, A
Ludwig, WD
Götz, N
Viehmann, S
Gadner, H
Riehm, H
Schrappe, M
BLOOD, 1999, 94 (04) : 1209 - 1217
[2] Treatment of infant acute lymphoblastic leukemia in Japan
Nishimura, S
Kobayashi, M
Ueda, K
Ishii, E
Okamura, J
Kawa-Ha, K
Akiyama, Y
Imashuku, S
Horibe, K
Matsuyama, T
Shibuya, A
Imaizumi, M
Tsukimoto, I
Nagao, T
INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 69 (04) : 244 - 252
[3] Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
Dördelmann, M
Harbott, J
Reiter, A
Ludwig, WD
Welte, K
Götz, N
Gadner, H
Riehm, H
Schrappe, M
BLOOD, 1998, 92 (10) : 480A - 481A
[4] TREATMENT AND OUTCOME OF INFANT ACUTE LYMPHOBLASTIC LEUKEMIA IN DEVELOPING WORLD: A SINGLE CENTRE EXPERIENCE
Ramzan, Mohammed
Yadav, Satya Prakash
Dua, Vikas
Dinand, Veronique
Manchanda, Himani
Anjan, Madasu
Sachdeva, Anand
PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 763 - 763
[5] Treatment outcome of adolescents with acute lymphoblastic leukemia
Irken, G
Ören, H
Gülen, H
Duman, M
Uçar, C
Atabay, B
Yilmaz, S
Uysal, K
Çevik, N
ANNALS OF HEMATOLOGY, 2002, 81 (11) : 641 - 645
[6] Treatment outcome of adolescents with acute lymphoblastic leukemia
G. İrken
H. Ören
H. Gülen
M. Duman
C. Uçar
B. Atabay
Ş. Yılmaz
K. Uysal
N. Çevik
Annals of Hematology, 2002, 81 : 641 - 645
[7] Recent progress in the treatment of infant acute lymphoblastic leukemia
Tomizawa, Daisuke
PEDIATRICS INTERNATIONAL, 2015, 57 (05) : 811 - 819
[8] Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia
Nachman, James B.
Heerema, Nyla A.
Sather, Harland
Camitta, Bruce
Forestier, Erik
Harrison, Christine J.
Dastugue, Nicole
Schrappe, Martin
Pui, Ching-Hon
Basso, Giuseppe
Silverman, Lewis B.
Janka-Schaub, Gritta E.
BLOOD, 2007, 110 (04) : 1112 - 1115
[9] Infant Acute Lymphoblastic Leukemia in Honduras
Medina, R.
Flores, J.
Rivera, A.
Aguilar, C.
Arambu, I.
Fu, L.
PEDIATRIC BLOOD & CANCER, 2020, 67 : S430 - S431
[10] Blinatumomab for infant acute lymphoblastic leukemia
Clesham, Katherine
Rao, Vasudha
Bartram, Jack
Ancliff, Philip
Ghorashian, Sara
O'Connor, David
Pavasovic, Vesna
Rao, Anupama
Samarasinghe, Sujith
Cummins, Michelle
Malone, Andrea
Patrick, Katharine
Bonney, Denise
James, Beki
Gibson, Brenda
Vora, Ajay
BLOOD, 2020, 135 (17) : 1501 - 1504

← 1 2 3 4 5 →